Veru VERU
NASDAQ VERU
$2.54 -0.12 (-4.51%)
At close: Oct 1, 2026 · 4:00 PM EDT

Veru (VERU) Total Non-Current Liabilities (2011 - 2026)

Updated

Veru (VERU) posted Total Non-Current Liabilities of $8.06 million for fiscal Q3 2026 (quarter ended Jun 30, 2026), down 12.2% from $9.18 million a year earlier but up 8.2% from the prior quarter.

Analysis

Veru (VERU) Total Non-Current Liabilities (2011 - 2026) Analysis & Trends

At the end of FY2025 (ended Sep 30, 2025), Veru's Total Non-Current Liabilities came in at $10.14 million, down 57.1% from FY2024.

  • Annual Total Non-Current Liabilities has declined for three consecutive fiscal years, with a five-year compound annual growth rate of -13.9% (FY2020 to FY2025).
  • In prior fiscal years, Veru's Total Non-Current Liabilities was $23.64 million in FY2024 (-22.0%), $30.31 million in FY2023 (-42.3%), $52.54 million in FY2022 (+122.5%) and $23.61 million in FY2021 (+10.3%).
  • Quarterly Total Non-Current Liabilities has run from a low of $7.45 million in fiscal Q2 2026 to a high of $52.54 million in fiscal Q4 2022 over five years.
  • On a year-over-year basis, Total Non-Current Liabilities increased in 1 of the last seven quarters, with an average decline of 31.3%.
  • The strongest year-over-year quarter for Total Non-Current Liabilities in the past five years was fiscal Q4 2022, with growth of 122.5%; the weakest was fiscal Q2 2025, with a decline of 61.8%.
  • According to Business Quant data, Total Non-Current Liabilities for the three prior fiscal quarters was $7.45 million (Q2 2026), $9.34 million (Q1 2026) and $10.14 million (Q4 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Total Non-Current Liabilities (Qtr)
1 Johnson & Johnson 638.12 Bn 556.64 Bn 17.26 Bn 105.99 Bn
2 AbbVie 462.60 Bn 435.75 Bn 12.70 Bn 106.45 Bn
3 Merck 358.70 Bn 313.13 Bn 12.21 Bn 80.25 Bn
4 Novartis Ag 272.16 Bn 228.03 Bn 11.24 Bn 48.34 Bn
5 Astrazeneca 250.36 Bn 223.92 Bn 12.86 Bn -967.00 Mn
6 Amgen 227.87 Bn 183.27 Bn 7.24 Bn 81.11 Bn
7 Gilead Sciences 184.97 Bn 159.08 Bn 6.22 Bn 36.04 Bn
8 Pfizer 162.61 Bn 109.56 Bn 10.94 Bn 100.86 Bn
9 Vertex Pharmaceuticals 132.45 Bn 104.46 Bn 2.84 Bn 5.92 Bn
10 Veru 61.31 Mn -48.96 Mn - 8.06 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 8.06 Mn
Mar 31, 2026 7.45 Mn
Dec 31, 2025 9.34 Mn
Sep 30, 2025 10.14 Mn
Jun 30, 2025 9.18 Mn
Mar 31, 2025 8.26 Mn
Dec 31, 2024 9.12 Mn
Sep 30, 2024 23.64 Mn
Jun 30, 2024 22.27 Mn
Mar 31, 2024 21.60 Mn
Sep 30, 2023 30.31 Mn
Jun 30, 2023 39.52 Mn
Mar 31, 2023 48.49 Mn
Dec 31, 2022 52.06 Mn
Sep 30, 2022 52.54 Mn
Jun 30, 2022 43.69 Mn
Mar 31, 2022 36.81 Mn
Dec 31, 2021 24.15 Mn
Sep 30, 2021 23.61 Mn
Jun 30, 2021 25.09 Mn
API Access

Veru Total Non-Current Liabilities API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=total-non-current-liabilities&ticker=VERU&period=max&api_key=YOUR_API_KEY